[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fyPPj0aeMh3kf1RU0SXaikZaXBx5O8msWl--ELqfABaQ":8,"$frQOaL_d8qn6MNyPmt1iQ4Kcps6NWbFpvJqEzvvZjPHo":55,"$fHAH16AAuS-6zZ3QbNOj-38ktNAqFlhJ4HRRMOzWnlz4":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75545,867105,[],"https://ystcdn.venuertc.com/medical/ystApp/IvFzoqgw629f7eIt8XG1lmFMah47ihUl.png","安秀朋","聊城市第二人民医院","甲状腺乳腺外科","主治医师",91,0,"乳腺癌分期3常用药物实用指南：关键用药细节一览","","https://ystcdn.venuertc.com/venue/AI/bc8dea70-97cc-4004-8888-699f68660c20.jpg","\u003Csection class=\"breast-drug-section\">\n  \u003C!-- 标题 -->\n  \u003Cdiv class=\"breast-drug-title-wrap\">\n    \u003Ch1 id=\"material_title\" class=\"breast-drug-main-title\">乳腺癌分期3常用药物实用指南：关键用药细节一览\u003C/h1>\n    \u003Cdiv class=\"breast-drug-intro-text\">\n      用药安全\u003Cspan class=\"breast-drug-emoji\">💊\u003C/span>无小事。针对乳腺癌分期3，药物治疗往离不开化疗、内分泌及靶向等多种药品（如白蛋白紫杉醇、吡柔比星、环磷酰胺等）。正确使用这些药物，能决定疗程效果和耐受性。这份指南将用7个实用细节，帮助你和家人掌握各类药品的使用规范、注意事项、可能的副作用及安全存放方法。不仅提高疗效\u003Cspan class=\"breast-drug-emoji\">👍\u003C/span>，更为安心添保障。  \n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 01 药品类型与作用机制 -->\n  \u003Csection class=\"breast-drug-bg1\">\n    \u003Ch2 class=\"breast-drug-sub-title\">\u003Cspan class=\"breast-drug-emoji\">🔬\u003C/span>01 常用药品类型及作用机制\u003C/h2>\n    \u003Cdiv class=\"breast-drug-body-text\">\n      乳腺癌分期3治疗常选用这几类药物：\u003Cbr>\n      \u003Cstrong>1. 紫杉类药物（如白蛋白结合型紫杉醇）\u003C/strong>  \n      通过抑制微管蛋白，使癌细胞停止分裂，发挥杀伤作用。\u003Cbr>\n      \u003Cstrong>2. 炔雌醇抑制药（如芳香化酶抑制剂）\u003C/strong>\u003Cbr>\n      阻断体内雌激素的生成，减少激素对肿瘤生长的影响。\u003Cbr>\n      \u003Cstrong>3. 烷化剂（如环磷酰胺）\u003C/strong>\u003Cbr>\n      通常破坏癌细胞DNA，阻断细胞增殖。\u003Cbr>\n      \u003Cstrong>4. 蒽环类药物（如吡柔比星等）\u003C/strong>\u003Cbr>\n      直接插入癌细胞DNA，并形成自由基导致细胞死亡。\u003Cbr>\n      \u003Cstrong>5. 靶向药物（如曲妥珠单抗等）\u003C/strong>\u003Cbr>\n      精准识别肿瘤细胞表面靶点，实现精准杀伤。\u003Cbr>\n      各药品有其各自机制，实际用药常需多种药物联合以增强疗效。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 药品剂型与使用方法讲解 -->\n  \u003Csection class=\"breast-drug-bg2\">\n    \u003Ch2 class=\"breast-drug-sub-title\">\u003Cspan class=\"breast-drug-emoji\">🧪\u003C/span>02 药品剂型与具体用法\u003C/h2>\n    \u003Cdiv class=\"breast-drug-body-text\">\n      绝大多数乳腺癌分期3用药为注射剂型（静脉滴注），少数（如内分泌药）为片剂/胶囊口服。不同剂型用法有严格要求：\u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>注射剂型：\u003C/strong>如白蛋白紫杉醇、吡柔比星、环磷酰胺，均通过静脉滴注，由专业医护在无菌环境下操作。禁自行注射。\u003C/li>\n        \u003Cli>\u003Cstrong>口服药品：\u003C/strong>包括常见的内分泌制剂（他莫昔芬）或部分辅助药物。须按照医生处方定时足量服用，切忌漏服或擅自加量。\u003C/li>\n      \u003C/ul>\n      正确做法：\u003Cbr>\n      \u003Cul>\n        \u003Cli>静脉输注药物时，确保管路通畅，严格按规定滴速，配合观察。\u003C/li>\n        \u003Cli>片剂一般建议整片吞服，避免掰碎或咀嚼，常用温开水送服。\u003C/li>\n        \u003Cli>如出现不适应及时告知医护。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"breast-drug-quote\">案例：临床上，化疗患者使用白蛋白紫杉醇输注过程中，每30分钟观察一次有无局部刺激或过敏。输注全程无异常者，药效发挥较为稳定。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 用药时间和给药方案-->\n  \u003Csection class=\"breast-drug-bg3\">\n    \u003Ch2 class=\"breast-drug-sub-title\">\u003Cspan class=\"breast-drug-emoji\">⏰\u003C/span>03 正确用药时机与疗程方案\u003C/h2>\n    \u003Cdiv class=\"breast-drug-body-text\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>静脉化疗药物\u003C/strong>，如白蛋白紫杉醇，多采用每1-3周一次，连续几个周期，疗程由医生制定，绝不可随意改变。\u003C/li>\n        \u003Cli>\u003Cstrong>口服药\u003C/strong>（如他莫昔芬）通常需每日服用1次，最好在固定时间，用温水整片送服。\u003C/li>\n        \u003Cli>化疗时间多安排在白天，以便及时发现不良反应，夜间尽量避免。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"breast-drug-tip\">需要注意：超时用药或随意停药，会影响疗效及耐药风险。每个周期间隔应严格遵循医生建议。\u003C/span>\n      \u003Cbr>如果忘记口服药品，第一时间补服，间隔较短则直接服用下一次，不可一次两倍。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 特殊人群的用药调整 -->\n  \u003Csection class=\"breast-drug-bg4\">\n    \u003Ch2 class=\"breast-drug-sub-title\">\u003Cspan class=\"breast-drug-emoji\">👵👶\u003C/span>04 特殊人群用药调整\u003C/h2>\n    \u003Cdiv class=\"breast-drug-body-text\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>老年人：\u003C/strong>肝肾功能减弱，常需在医生评估肝肾功能后适度调低剂量，并加强不良反应监测。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝、肾功能损伤患者：\u003C/strong>使用抗癌化疗药（如吡柔比星、环磷酰胺），剂量及给药间隔需个体化调整，避免毒性蓄积。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>孕妇、哺乳期女性：\u003C/strong>绝大多数抗肿瘤药物为妊娠禁用，严格避孕；哺乳需暂停。遵循医嘱后再评估恢复时间。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>儿童：\u003C/strong>本类药品多无儿童使用推荐，若特殊情形，用药前务必经严格体表面积换算及评估。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"breast-drug-tip\">\n        特别提醒：每一次剂量更改、疑虑、脱漏、过量等情况，建议第一时间联系专科医生，严禁自行决定。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 药物相互作用及合用药物注意 -->\n  \u003Csection class=\"breast-drug-bg5\">\n    \u003Ch2 class=\"breast-drug-sub-title\">\u003Cspan class=\"breast-drug-emoji\">⚠️\u003C/span>05 药物相互作用禁忌和合用药注意\u003C/h2>\n    \u003Cdiv class=\"breast-drug-body-text\">\n      多种抗肿瘤药物联合方案常见，合理搭配可提升疗效，但也增加了相互作用风险：\u003Cbr>\n      \u003Cstrong>1. 化疗药和支持用药\u003C/strong>\u003Cbr>\n      \u003Cul>\n        \u003Cli>化疗期间常合用止吐药、护肝药。可减少不良反应，但伴随影响降解代谢途径，部分药品如吡柔比星与某些抗生素同用时，心脏毒性风险上升。\u003C/li>\n        \u003Cli>不可自行增减辅助药用量，应听从医生安排。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>2. 静脉化疗药与其他治疗药\u003C/strong>\u003Cbr>\n      \u003Cul>\n        \u003Cli>如合用抗真菌药或抗癫痫药，可能抑制（或加速）部分化疗药物代谢，导致药效增强或过度蓄积。\u003C/li>\n        \u003Cli>配伍禁忌药物绝不能同瓶混用，例如吡柔比星不可与碱性药物或高浓度盐水同时滴注。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"breast-drug-quote\">研究数据显示，白蛋白紫杉醇与某些强CYP3A4抑制剂同用时，药物血中浓度可增加40%（Gradishar, 2007）。\u003C/div>\n      \u003Cstrong>3. 食物影响\u003C/strong>\u003Cbr>\n      \u003Cul>\n        \u003Cli>部分口服化疗药需空腹服用，勿与葡萄柚同服（抑制肝酶，影响代谢）。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 常见不良反应及处理 -->\n  \u003Csection class=\"breast-drug-bg6\">\n    \u003Ch2 class=\"breast-drug-sub-title\">\u003Cspan class=\"breast-drug-emoji\">🚑\u003C/span>06 常见不良反应和处理方法\u003C/h2>\n    \u003Cdiv class=\"breast-drug-body-text\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>白蛋白紫杉醇：\u003C/strong>最常见为轻中度脱发、手足麻木、偶有输注部位红肿。严重过敏反应发生率小于2%。\u003C/li>\n        \u003Cli>\u003Cstrong>吡柔比星：\u003C/strong>可能出现口腔黏膜发炎、恶心，长期累及心肌（心力衰竭少见: <3%）。\u003C/li>\n        \u003Cli>\u003Cstrong>环磷酰胺：\u003C/strong>有时导致出血性膀胱炎，喝足量水有助预防。极少数可出现过敏。\u003C/li>\n        \u003Cli>\u003Cstrong>内分泌制剂：\u003C/strong>多见潮热、出汗，较少骨质疏松等。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"breast-drug-tip\">\n        正确做法：出现轻度不适，如恶心、轻微脱发等可暂时观察，如有明显呼吸困难、全身皮疹、持续高热、心悸等，立即就诊。\n      \u003C/span>\n      \u003Cdiv class=\"breast-drug-quote\">一位45岁女性多次标准化疗期间出现脱发和手脚麻木，输注护理得当后未出现严重并发症，药物效果良好。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 药品储存及有效期管理 -->\n  \u003Csection class=\"breast-drug-bg7\">\n    \u003Ch2 class=\"breast-drug-sub-title\">\u003Cspan class=\"breast-drug-emoji\">🗄️\u003C/span>07 药品储存方法与过期处理\u003C/h2>\n    \u003Cdiv class=\"breast-drug-body-text\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>注射剂型：\u003C/strong>常温避光储存，不能冷冻。已配药未使用部分需及时丢弃，切忌留存备用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>口服剂型：\u003C/strong>原包装密封，放于干燥阴凉处远离儿童。部分药物（如他莫昔芬）需避免长期高温、潮湿环境。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>药品有效期：\u003C/strong>定期检查药品包装上有效期。超过有效期禁止使用，即使外观正常亦丢弃。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>丢弃方法：\u003C/strong>建议用塑料袋封口后随生活垃圾处理，避免随意丢弃造成误食或环境污染。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>标记：\u003C/strong>用药盒或标签区分不同周期药品，防止混淆。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 结语，总结与强调 -->\n  \u003Csection class=\"breast-drug-summary\">\n    \u003Ch2 class=\"breast-drug-sub-title\">\u003Cspan class=\"breast-drug-emoji\">✅\u003C/span>用药指南速读总结\u003C/h2>\n    \u003Cdiv class=\"breast-drug-body-text\">\n      不同抗肿瘤药物各有其安全细节。\u003Cbr>\n      \u003Cstrong>最重要的两点：\u003C/strong>\u003Cbr>\n      \u003Cul>\n        \u003Cli>严格遵医嘱，按规定途径、剂量和周期用药。\u003C/li>\n        \u003Cli>出现新不适或疑虑，务必及时与专业人员联系。\u003C/li>\n      \u003C/ul>\n      复杂方案、联合化疗、细致的服药管理相信都能掌握得当。科学存放药物、警惕副作用发生，能让家庭用药更安心。\u003Cbr>\n      关注药品本身，懂得用药安全，才是真正给治疗添上“好尾巴”。\u003Cspan class=\"breast-drug-emoji\">🌈\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 文献引用 -->\n  \u003Csection class=\"breast-drug-ref\">\n    \u003Ch3 class=\"breast-drug-ref-title\">参考文献\u003C/h3>\n    \u003Col class=\"breast-drug-ref-list\">\n      \u003Cli>\n        \u003Cspan>Gradishar, W. J. (2007). Albumin-bound paclitaxel: a next-generation taxane. Expert Opinion on Pharmacotherapy, 8(13), 2139-2149.\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan>Martin, L. A., & Dowsett, M. (2008). Endocrine therapy for breast cancer: pharmacology, efficacy and resistance. Trends in Pharmacological Sciences, 29(6), 312-319.\u003C/span>\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan>Jassem, J. (2014). Chemotherapy in advanced breast cancer: standards and controversies. Breast, 23(2), 207-217.\u003C/span>\n      \u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/section>\n\n\u003Cstyle>\n/* 独立样式，避免污染全局 */\n.breast-drug-section {\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Hiragino Sans GB\", \"Microsoft YaHei\", \"WenQuanYi Micro Hei\", sans-serif;\n  color: #232425;\n  background-color: #faf9fc;\n  padding: 40px 16px 60px 16px;\n  max-width: 800px;\n  margin: 34px auto;\n  border-radius: 12px;\n  box-shadow: 0 6px 18px 0 rgba(48, 60, 60, 0.05);\n}\n.breast-drug-main-title {\n  font-size: 2.2em;\n  font-weight: 700;\n  margin: 0 0 16px 0;\n  color: #2973b4;\n  letter-spacing: 1.5px;\n  text-shadow: 0px 2px 4px #e1eefd;\n}\n.breast-drug-intro-text {\n  font-size: 1.13em;\n  color: #505050;\n  background: #eef5fb;\n  padding: 17px 18px 14px 18px;\n  border-radius: 9px;\n  margin-bottom: 30px;\n  word-break: break-word;\n  font-weight: 500;\n  box-shadow: 0px 1px 5px 0 rgba(87,120,219,.04);\n}\n.breast-drug-emoji { margin: 0 2px; }\n\n.breast-drug-sub-title {\n  font-size: 1.45em;\n  font-weight: bold;\n  color: #225d92;\n  margin: 0 0 12px 0;\n  letter-spacing: 0.5px;\n  padding-left: 10px;\n  text-shadow: 0px 1px 3px #def2dc79;\n}\n\n.breast-drug-bg1, .breast-drug-bg2, .breast-drug-bg3, .breast-drug-bg4, .breast-drug-bg5, .breast-drug-bg6, .breast-drug-bg7 {\n  background: url(\"data:image/svg+xml,%3Csvg width='260' height='120' viewBox='0 0 260 120' xmlns='http://www.w3.org/2000/svg'%3E%3Cellipse fill='%23eaf5fd' cx='130' cy='60' rx='120' ry='44'/%3E%3C/svg%3E\"); \n  background-size: 100% 56px;\n  background-repeat: no-repeat;\n  background-position: top left;\n  margin-bottom: 34px;\n  border-radius: 8px;\n  padding: 30px 18px 16px 18px;\n  box-shadow: 0 1px 8px 0 rgba(168,193,212,0.07);\n}\n\n.breast-drug-body-text {\n  font-size: 1.10em;\n  color: #303030;\n  line-height: 1.85;\n  word-break: break-word;\n}\n.breast-drug-body-text ul {\n  margin: 11px 0 11px 28px;\n  padding: 0;\n}\n.breast-drug-body-text li {\n  margin-bottom: 7px;\n}\n.breast-drug-tip {\n  display:inline-block;\n  background: #fff6d6;\n  color: #876a1f;\n  border-radius: 5px;\n  padding: 7px 10px;\n  font-size: 1em;\n  margin: 12px 0;\n  font-weight: 600;\n}\n.breast-drug-quote {\n  background: #eaf5fd;\n  color: #556270;\n  border-left: 4px solid #2973b4;\n  padding: 8px 15px;\n  border-radius: 6px;\n  margin: 17px 0 7px 0;\n  font-size: 1em;\n  font-style: italic;\n}\n.breast-drug-summary {\n  background: #eaf9ef;\n  box-shadow: 0 1px 6px 0 rgba(85,216,151,0.11);\n  padding: 27px 18px 16px 18px;\n  margin: 33px 0 24px 0;\n  border-radius: 9px;\n}\n.breast-drug-summary ul {\n  margin: 10px 0 10px 28px;\n}\n.breast-drug-ref {\n  background: #f7fafe;\n  border-radius: 8px;\n  padding: 16px 22px 7px 18px;\n  box-shadow: 0 1px 5px 0 rgba(43,92,184,0.07);\n  margin: 15px 0 13px 0;\n}\n.breast-drug-ref-title {\n  font-size: 1.13em;\n  font-weight: bold;\n  color: #237ab9;\n  padding-top: 5px;\n  letter-spacing: .5px;\n  margin-bottom: 12px;\n}\n.breast-drug-ref-list {\n  margin-left: 18px;\n  font-size: 1em;\n  color: #383c4d;\n}\n@media (max-width: 600px) {\n  .breast-drug-section {\n    padding: 21px 3vw;\n    font-size: 1em;\n  }\n  .breast-drug-bg1, .breast-drug-bg2, .breast-drug-bg3, .breast-drug-bg4, .breast-drug-bg5, .breast-drug-bg6, .breast-drug-bg7 {\n    padding: 19px 7px 13px 9px;\n    background-size: 94% 36px;\n  }\n  .breast-drug-main-title {\n    font-size: 1.25em;\n  }\n}\n\u003C/style>","\u003Csection class=\"breast-drug-section\">\n  \u003C!-- 标题 -->\n  \u003Cdiv class=\"breast-drug-title-wrap\">\n    \u003Ch1 i",561,"2025-12-06 01:19:32","乳腺癌药物, 化疗药物, 靶向药物, 使用指南, 用药安全, 乳腺癌治疗, 药物副作用, 用药注意事项","掌握乳腺癌分期3的药物使用要点，了解化疗、靶向药物等治疗细节，确保用药安全，为患者提供有效保障。","2025-12-15 14:59:35",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]